IUDs Effective as Emergency Contraception
Data collected over 35 years shows that the use of intrauterine devices as emergency contraception has a 99.86 percent success rate. The findings prompted researchers at Princeton University to conclude that the devices could be routinely promoted as a defense against unwanted pregnancy.
Data collected over 35 years shows that the use of intrauterine devices as emergency contraception has a 99.86 percent success rate. The findings prompted researchers at Princeton University to conclude that the devices could be routinely promoted as a defense against unwanted pregnancy.
More than a third of pregnancies worldwide and nearly half in the United States are unintended. –ARK
Wait, before you go…MedPage Today:
In a review of 35 years of data in which IUDs were inserted after unprotected intercourse, 99.86% of [women overall] did not become pregnant, reported Kelly Cleland, a research scientist at Princeton University in New Jersey, and colleagues in Human Reproduction.
Unintended pregnancy is a signicant problem, with at least 36% of pregnancies worldwide and nearly half of pregnancies in the U.S. being unintended, the authors noted in their introduction. Emergency contraception is a popular method for preventing unwanted pregnancy, with oral methods such as levonorgestrel (Plan B) and ulipristal acetate (Ella or EllaOne), among the leading medications used.
Although IUDs are another option, negative experiences with the Dalkon Shield in the 1970s led to years of low IUD use, the authors pointed out. But one of the major advantages of copper IUDs is that after placement for emergency contraception, the device can be left in and will continue to prevent pregnancy for at least a decade.
If you're reading this, you probably already know that non-profit, independent journalism is under threat worldwide. Independent news sites are overshadowed by larger heavily funded mainstream media that inundate us with hype and noise that barely scratch the surface. We believe that our readers deserve to know the full story. Truthdig writers bravely dig beneath the headlines to give you thought-provoking, investigative reporting and analysis that tells you what’s really happening and who’s rolling up their sleeves to do something about it.
Like you, we believe a well-informed public that doesn’t have blind faith in the status quo can help change the world. Your contribution of as little as $5 monthly or $35 annually will make you a groundbreaking member and lays the foundation of our work.
Support Truthdig
Half of U.S. physicians are “disengaged, burned out, and demoralized and plan to either retire, cut back on work hours, or seek non-clinical roles,” according to a new survey.Half of physicians nationwide are “disengaged, burned out, and demoralized and plan to either retire, cut back on work hours, or seek non-clinical roles,” according to a new survey.
Medical societies and paid drug industry researchers have loaded society up with new definitions of alleged ill health from which drug companies can profit when millions of otherwise well people are labeled as ailing.
Wall Street’s drive for profits is diminishing the benefits to society of new life-enhancing medications for which companies can charge patients hundreds of thousands of dollars per year.
A recent study showed that the highest rates of burnout in the medical profession were found among front-line physicians: family doctors, internal specialists, neurologists and -- in particular -- emergency MDs.
The first large analysis of takotsubo, or “broken-heart syndrome,” shows that the condition can be just as deadly as other cardiovascular diseases -- and that most victims are female.
Though Humulin has been on the market for many years for a relatively cheap price, a single monthlong dose of the insulin variety manufactured by Eli Lilly costs $1,200 today -- more than five times the amount in 2007. Why? Because the company can charge that much, Eli Lilly's insulin marketing director said.
There are currently no responses to this article.
Be the first to respond.